Rapid Microbiology Testing Market Report, By Method, Product, Application, End User (Laboratories & Hospitals, Food & Beverage Companies, Pharmaceutical & Biotechnology Companies, Contract Research Organizations) and Geography - Global Market Share, Trend Analysis & Forecast

Rapid microbiology testing are a broad group of analytical microbiological methods that share the common characteristic of delivering a result in less time than compendial, Pasteurian, labour-intensive methods. Apart from the reduced time consumption advantage, they present other advantages over compendial methods, including the possibility of automation and increased sensitivity and accuracy. Continuous technological advancements in microbiology testing, in terms of efficacy, efficiency, accuracy, faster results, and improved functionality, are generating increased interest among clinical laboratories, hospitals, academic institutes, research laboratories, and pharmaceutical and biotechnology companies.

Rapid Microbiology Testing Market Trends

• One of the chief factors boosting the growth of rapid microbiology test markets is the rising need for easy and fast diagnosis; other dynamics boosting this market comprise technological advancement, abridged cost, better patient fulfilment due to the removal of usage of antibiotics and other drugs, awaiting threat of communication of AIDS and augmented prospective of bioterrorism tests
• Progressions in molecular diagnostic technologies might pose a threat to the conventional rapid microbiology test market by producing the decrease in sales volume

Rapid Microbiology Testing Market Outlook

• Rapid microbiological testing technologies aim to provide more sensitive, accurate, precise, and reproducible test results when compared with conventional, growth-based methods
• Because microbiological testing is a bottleneck in product release, the pharmaceutical industry’s interest in rapid microbiological methods (RMMs) has grown considerably during the past ten years

Rapid Microbiology Testing Market COVID-19 Impact

• The healthcare sector is at the epicenter of this unprecedented global pandemic challenge, and the private sector has risen to the occasion, by offering to the government all the support it needs, be it testing support, preparing isolation beds for the treatment of COVID -19 positive patients or deploying equipment and staff in identified nodal hospitals
• The COVID-19 pandemic has surged the demand for rapid testing methods in order to identify the strain of virus 

Rapid Microbiology Testing Market Regional Trends

The global market is studied for the key regions such as, North America, Europe, Asia Pacific and Rest of the World. North America comprises of U.S., Canada and Mexico. Whereas, Europe covers UK, France, Germany, Italy, Spain and Rest of Europe. The key countries included under Asia Pacific are China, India, Japan and Rest of Asia Pacific. The Rest of the world include Latin America and Middle East & Africa. The North America accounted for the largest market share in 2019 in terms of revenue followed by Europe. Rising prevalence of various diseases among the population, refined healthcare infrastructure, and rising need for advanced diagnostic testing are the key reasons accounted for the market growth in North America. Developing economies of Asia Pacific such as India, are expected to experience a rapid expansion due to favorable laws being incorporated in the country. Moreover, the rise in prevalence and severity of diseases in emerging nations such as India, China, Indonesia, and Malaysia propel the growth in the region. 

Rapid Microbiology Testing Market Segmental Highlights

• The report analyses the global rapid microbiology testing industry based on method, product, application, end user and geography
• Various method studied in the report are growth-based rapid microbiology testing, cellular component-based rapid microbiology testing, nucleic acid-based rapid microbiology testing, viability-based rapid microbiology testing & other rapid microbiology testing methods
• The products of the industry are classified into instruments, reagents & kits & consumables. The instruments segment is further categorized into automated microbial identification and antimicrobial susceptibility testing systems, mass spectrometers, PCR systems, bioluminescence- and fluorescence-based detection systems, cytometers, active air samplers, and other instruments. Also, reagents & kits majorly comprise of sterility testing reagents & kits and other reagents & kits
• Furthermore, several applications of the industry are segmented into clinical disease diagnosis, food & beverage testing, pharmaceutical & biological drug testing, environmental testing, cosmetics & personal care products testing and research applications and other applications
• The end users of rapid microbiology testing industry are diagnostic laboratories & hospitals, food & beverage companies, pharmaceutical & biotechnology companies, contract research organizations, and other end users 

Rapid Microbiology Testing Market Key Players

The key competitors of this market include bioMérieux SA (France). Abbott Laboratories Inc. (US), Danaher Corporation (US), and Becton, Dickinson and Company (US), Bruker Corporation (US), Charles River Laboratories International, Inc. (US), Don Whitley Scientific Limited (UK), Merck KGaA (Germany), Neogen (US), Quidel Corporation (US), Rapid Micro Biosystems, Inc. (US), Sartorius Group (Germany), Thermo Fisher Scientific (US), TSI Inc. (US), and Vivione Biosciences, LLC (US). 

The microbiology testing market has witnessed new product launches, mergers and acquisitions, partnerships, joint ventures, and strategies adopted by the major players to gain competitive advantage. The companies are also introducing advanced microbiological automated systems that have high throughputs and are less time-consuming.